{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:24Z","timestamp":1791341544490,"version":"4.3.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J08293"],"award-info":[{"award-number":["2025J08293"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218841","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:31:12Z","timestamp":1789860672000},"page":"218841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["T-cell exhaustion and senescence in cancer: Regulatory circuits and therapeutic state engineering"],"prefix":"10.1016","volume":"660","author":[{"given":"Jiashu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canlet.2026.218841_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/cyto.a.23724","article-title":"Comprehensive phenotyping of T cells using flow cytometry","volume":"95","author":"Mousset","year":"2019","journal-title":"Cytometry A"},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s43657-021-00031-0","article-title":"Mapping cell phenomics with multiparametric flow cytometry assays","volume":"2","author":"Liu","year":"2022","journal-title":"Phenomics"},{"key":"10.1016\/j.canlet.2026.218841_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.coche.2018.01.003","article-title":"Single-cell technologies for profiling T cells to enable monitoring of immunotherapies","volume":"19","author":"An","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.canlet.2026.218841_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1306169","article-title":"Current annotation strategies for T cell phenotyping of single-cell RNA-seq data","volume":"14","author":"Mullan","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib5","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.canlet.2026.218841_bib6","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41592-025-02793-1","article-title":"Reproducible single-cell annotation of programs underlying T cell subsets, activation states and functions","volume":"22","author":"Kotliar","year":"2025","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-024-01186-2","article-title":"Advances in single-cell omics and multiomics for high-resolution molecular profiling","volume":"56","author":"Lim","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218841_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4+T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.canlet.2026.218841_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218841_bib11","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ni.2538","article-title":"Distinct TCR signaling pathways drive proliferation and cytokine production in T cells","volume":"14","author":"Guy","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1038\/s41467-022-29979-x","article-title":"The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins","volume":"13","author":"Petkau","year":"2022","journal-title":"Nat. Commun."},{"issue":"71","key":"10.1016\/j.canlet.2026.218841_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh4271","article-title":"Persistent CAD activity in memory CD8(+) T cells supports rRNA synthesis and ribosomal biogenesis required at rechallenge","volume":"7","author":"Claiborne","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218841_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1548234","article-title":"Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies","volume":"16","author":"Nair","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2026.218841_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41590-020-0643-3","article-title":"Sestrins induce natural killer function in senescent-like CD8+ T cells","volume":"21","author":"Pereira","year":"2020","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib19","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1172\/JCI70355","article-title":"p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes","volume":"123","author":"Mondal","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib20","article-title":"Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence","volume":"5","author":"Dai","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"24","key":"10.1016\/j.canlet.2026.218841_bib21","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.3390\/cancers15245835","article-title":"Implications of senescent T cells for cancer immunotherapy","volume":"15","author":"Kasamatsu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/intimm\/dxae056","article-title":"Senescence-associated T cells in immunosenescence and diseases","volume":"37","author":"Fukushima","year":"2025","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002555","article-title":"Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies","volume":"9","author":"Tantalo","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112829","article-title":"Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8(+) activation","volume":"28","author":"Xu","year":"2025","journal-title":"iScience"},{"issue":"30","key":"10.1016\/j.canlet.2026.218841_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304319120","article-title":"IL-7R licenses a population of epigenetically poised memory CD8(+) T cells with superior antitumor efficacy that are critical for melanoma memory","volume":"120","author":"Micevic","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib90","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1038\/s41467-021-24619-2","article-title":"Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development","volume":"12","author":"He","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218841_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1629802","article-title":"Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses","volume":"15","author":"Schmidt","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218841_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1605972","article-title":"Epigenetic control of tissue resident memory T cells","volume":"16","author":"Lan","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib116","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/1878-0261.13793","article-title":"Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia","volume":"19","author":"Rezaeifar","year":"2025","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s42003-023-04631-6","article-title":"CD83 expression characterizes precursor exhausted T cell population","volume":"6","author":"Wu","year":"2023","journal-title":"Commun. Biol."},{"issue":"8059","key":"10.1016\/j.canlet.2026.218841_bib52","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41586-024-08451-4","article-title":"Precursors of exhausted T cells are pre-emptively formed in acute infection","volume":"640","author":"Chu","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.canlet.2026.218841_bib85","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/s41590-025-02257-w","article-title":"SATB1 is a key regulator of quiescence in stem-like CD8(+) T cells","volume":"26","author":"Lin","year":"2025","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib92","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.canlet.2026.218841_bib51","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2026.218841_bib53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib57","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.canlet.2026.218841_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.191220","article-title":"Faithful modeling of terminal CD8+T cell dysfunction and epigenetic stabilization in vitro","volume":"10","author":"Yousif","year":"2025","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.canlet.2026.218841_bib81","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41590-021-00982-6","article-title":"Differentiation of exhausted CD8(+) T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory","volume":"22","author":"Tonnerre","year":"2021","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12943-025-02517-1","article-title":"Immune cell senescence drives responsiveness to immunotherapy in melanoma","volume":"24","author":"Pantelis","year":"2025","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib24","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41596-021-00505-5","article-title":"Algorithmic assessment of cellular senescence in experimental and clinical specimens","volume":"16","author":"Kohli","year":"2021","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41467-017-02689-5","article-title":"Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.canlet.2026.218841_bib101","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218841_bib103","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","article-title":"CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors","volume":"21","author":"Wang","year":"2020","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib72","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218841_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1562248","article-title":"Deciphering the deterministic role of TCR signaling in T cell fate determination","volume":"16","author":"Qin","year":"2025","journal-title":"Front. Immunol."},{"issue":"822","key":"10.1016\/j.canlet.2026.218841_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adh0439","article-title":"Cbl-b mitigates the responsiveness of naive CD8(+) T cells that experience extensive tonic T cell receptor signaling","volume":"17","author":"Eggert","year":"2024","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250238","article-title":"Regulatory T-cell-derived interleukin-15 shapes cytotoxic T cell memory","volume":"53","author":"Geginat","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Guti\u00e9rrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218841_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012350","article-title":"Clonally expanded effector CD4(+) cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy","volume":"13","author":"Giguelay","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib61","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4+ T cells in cancer: expanding the immune effector toolbox","volume":"54","author":"Oh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218841_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2024.11.003","article-title":"Decoding T cell senescence in cancer: is revisiting required?","volume":"108","author":"Magkouta","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218841_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2018.00201","article-title":"Proximity of cytomegalovirus-specific CD8+ T cells to replicative senescence in human immunodeficiency virus-infected individuals","volume":"9","author":"Heath","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/medsci13030190","article-title":"Advances in adoptive cell therapies in cancer: from mechanistic breakthroughs to clinical frontiers and overcoming barriers","volume":"13","author":"Rabbani","year":"2025","journal-title":"Med. Sci."},{"key":"10.1016\/j.canlet.2026.218841_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1665488","article-title":"Recent advances in adoptive cell therapy for cancer immunotherapy","volume":"16","author":"Qian","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12935-025-03938-0","article-title":"Advancements and challenges in CAR-T cell therapy for solid tumors: a comprehensive review of antigen targets, strategies, and future directions","volume":"25","author":"Zhu","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-025-01744-9","article-title":"Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?","volume":"18","author":"Vo","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218841_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117252","article-title":"Antigen escape in CAR-T cell therapy: mechanisms and overcoming strategies","volume":"178","author":"Lin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218841_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835762","article-title":"Cancer therapy with TCR-engineered T cells: current strategies, challenges, and prospects","volume":"13","author":"Shafer","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T cell therapy in solid tumors: state of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40364-023-00534-0","article-title":"Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges","volume":"11","author":"Pang","year":"2023","journal-title":"Biomark. Res."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012029","article-title":"Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"23","key":"10.1016\/j.canlet.2026.218841_bib38","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-025-00957-5","article-title":"Tumor-infiltrating lymphocyte therapy for the treatment of metastatic melanoma","volume":"26","author":"Tsai","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"issue":"7870","key":"10.1016\/j.canlet.2026.218841_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218841_bib43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1158\/2326-6066.CIR-25-0384","article-title":"A dual role for NKG7 in T-cell cytotoxicity and longevity","volume":"13","author":"Dong","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s12276-025-01448-7","article-title":"Progressive accumulation of circulating CD27(-)CD28(-) effector\/memory CD8(+) T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapy","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib47","first-page":"460","article-title":"The mechanisms and clinical significance of CD8(+) T cell exhaustion in anti-tumor immunity","volume":"22","author":"Zhong","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8(+) T cell exhaustion","volume":"26","author":"Sun","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218841_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1204363","article-title":"Strategies to reinvigorate exhausted CD8(+) T cells in tumor microenvironment","volume":"14","author":"Guan","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218841_bib54","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/2326-6066.CIR-24-1228","article-title":"Tumor-derived EBI3 promotes CD8+ T-cell exhaustion via STAT4-IL10\/CCL5 in gastric cancer","volume":"13","author":"Yan","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/imm.13575","article-title":"Metabolic plasticity and regulation of T cell exhaustion","volume":"167","author":"Li","year":"2022","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib58","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.immuni.2023.11.005","article-title":"Stat5 opposes the transcription factor Tox and rewires exhausted CD8(+) T cells toward durable effector-like states during chronic antigen exposure","volume":"56","author":"Beltra","year":"2023","journal-title":"Immunity"},{"issue":"42","key":"10.1016\/j.canlet.2026.218841_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw3571","article-title":"Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure","volume":"11","author":"Yin","year":"2025","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.canlet.2026.218841_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010735","article-title":"STS2 deficiency revives CD8(+)T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy","volume":"13","author":"Sun","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib65","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220686","article-title":"STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection","volume":"220","author":"Sun","year":"2023","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.canlet.2026.218841_bib66","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.molcel.2025.09.005","article-title":"Lipid-regulated phosphorylation hierarchy of the T cell receptor tyrosine motifs","volume":"85","author":"Li","year":"2025","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib67","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212012","article-title":"Regulating the discriminatory response to antigen by T-cell receptor","volume":"42","author":"Gangopadhyay","year":"2022","journal-title":"Biosci. Rep."},{"issue":"11","key":"10.1016\/j.canlet.2026.218841_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70346","article-title":"A kinetic gatekeeper: tcr-pmhc dissociation dynamics determine T cell activation efficacy","volume":"34","author":"Yan","year":"2025","journal-title":"Protein Sci."},{"key":"10.1016\/j.canlet.2026.218841_bib69","article-title":"Atomistic TCR-ligand interactions instruct memory T-cell differentiation","author":"Akitsu","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib70","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200030","article-title":"TGF-\u03b2 and Eomes control the homeostasis of CD8+ regulatory T cells","volume":"218","author":"Mishra","year":"2021","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib71","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191287","article-title":"Early T-bet promotes LFA1 upregulation required for CD8+ effector and memory T cell development","volume":"220","author":"Pritchard","year":"2023","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s43018-024-00892-0","article-title":"ETV7 limits the antiviral and antitumor efficacy of CD8(+) T cells by diverting their fate toward exhaustion","volume":"6","author":"Cheng","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218841_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1576468","article-title":"TOX, through a glass, darkly","volume":"16","author":"Hogan","year":"2025","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.canlet.2026.218841_bib75","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1097\/CM9.0000000000003894","article-title":"Exosomal Ppar\u03b1 derived from cancer cells induces CD8+ T cell exhaustion in hepatocellular carcinoma through the miR-27b-3p\/TOX axis","volume":"138","author":"Zhong","year":"2025","journal-title":"Chin. Med. J. (Engl. Ed.)"},{"key":"10.1016\/j.canlet.2026.218841_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1559494","article-title":"The NF-\u03baB signaling network in the life of T cells","volume":"16","author":"Daniels","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112663","article-title":"NFAT and NF-\u03baB dynamically co-regulate TCR and CAR signaling responses in human T cells","volume":"42","author":"Huang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218841_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1627084","article-title":"Post-translational governance of NF-\u03baB in cancer immunity: mechanisms and therapeutic horizons","volume":"16","author":"Hong","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218841_bib79","article-title":"Epigenetic regulation of CD8(+) T cell exhaustion: recent advances and update","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib82","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/procel\/pwaf003","article-title":"Chromatin landscape alteration uncovers multiple transcriptional circuits during memory CD8+ T-cell differentiation","volume":"16","author":"Liu","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2026.218841_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1652398","article-title":"Super-enhancers in immune system regulation: mechanisms, pathological reprogramming, and therapeutic opportunities","volume":"16","author":"Lai","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib84","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221288","article-title":"CTCF mediates CD8+ effector differentiation through dynamic redistribution and genomic reorganization","volume":"220","author":"Liu","year":"2023","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib86","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1038\/s41467-021-26159-1","article-title":"Tcf1 and Lef1 provide constant supervision to mature CD8(+) T cell identity and function by organizing genomic architecture","volume":"12","author":"Shan","year":"2021","journal-title":"Nat. Commun."},{"issue":"7779","key":"10.1016\/j.canlet.2026.218841_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib89","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/s41467-025-58563-2","article-title":"Lactate activates trained immunity by fueling the tricarboxylic acid cycle and regulating histone lactylation","volume":"16","author":"Cai","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.canlet.2026.218841_bib91","doi-asserted-by":"crossref","first-page":"C1062","DOI":"10.1152\/ajpcell.00478.2024","article-title":"Metabolic T-cell phenotypes: from bioenergetics to function","volume":"328","author":"Jantz-Naeem","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218841_bib93","doi-asserted-by":"crossref","first-page":"616","DOI":"10.21147\/j.issn.1000-9604.2024.06.04","article-title":"Myeloid cells meet CD8+ T cell exhaustion in cancer: what, why and how","volume":"36","author":"Zhai","year":"2024","journal-title":"Chin. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218841_bib94","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing Anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib95","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","article-title":"Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer","volume":"185","author":"Nalio Ramos","year":"2022","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.canlet.2026.218841_bib96","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41591-018-0205-5","article-title":"Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib97","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006595","article-title":"CD71+ erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors","volume":"11","author":"Bozorgmehr","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218841_bib98","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41577-026-01303-4","article-title":"Immune regulation by erythroid cells: how erythroid progenitor cells and mature red blood cells shape immunity","volume":"26","author":"Elahi","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib99","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2026.2682649","article-title":"Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer","volume":"15","author":"Azimi","year":"2026","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006649","article-title":"CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-\u03b2","volume":"16","author":"Shahbaz","year":"2018","journal-title":"PLoS Biol."},{"issue":"24","key":"10.1016\/j.canlet.2026.218841_bib102","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1097\/CM9.0000000000003908","article-title":"Metabolic-immune nexus in tumor microenvironment: from mechanistic insights to therapeutic opportunities","volume":"138","author":"Zhu","year":"2025","journal-title":"Chin. Med. J. (Engl. Ed.)"},{"key":"10.1016\/j.canlet.2026.218841_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563049","article-title":"Early events in TCR signaling - the evolving role of ITAMs","volume":"16","author":"Love","year":"2025","journal-title":"Front. Immunol."},{"issue":"36","key":"10.1016\/j.canlet.2026.218841_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw2568","article-title":"PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/discim\/kyaf006","article-title":"CD28 and TCR differentially impact na\u00efve and memory T cell responses","volume":"4","author":"Williams","year":"2025","journal-title":"Discov. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib109","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.2300154","article-title":"ICOS-expressing regulatory T cells influence the composition of antitumor CTL populations","volume":"213","author":"Diamantopoulos","year":"2024","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.canlet.2026.218841_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116302","article-title":"T cell-intrinsic cGAS-CTCF regulation maintains regulatory T cell development and function","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib112","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1007\/s00262-023-03548-7","article-title":"ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1","volume":"72","author":"Enell Smith","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib113","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2030135","article-title":"An Fc-inert PD-L1\u00d74-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation","volume":"11","author":"Muik","year":"2022","journal-title":"Oncoimmunology"},{"issue":"15","key":"10.1016\/j.canlet.2026.218841_bib114","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1158\/1078-0432.CCR-21-2762","article-title":"The PD-L1\/4-1BB bispecific antibody-anticalin fusion protein PRS-344\/S095012 elicits strong T-Cell stimulation in a tumor-localized manner","volume":"28","author":"Peper-Gabriel","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-023-00375-5","article-title":"Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia","volume":"12","author":"Bozorgmehr","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib118","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib119","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212391","article-title":"Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits","volume":"219","author":"Whyte","year":"2022","journal-title":"J. Exp. Med."},{"issue":"7877","key":"10.1016\/j.canlet.2026.218841_bib120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41586-021-03861-0","article-title":"An engineered IL-2 partial agonist promotes CD8(+) T cell stemness","volume":"597","author":"Mo","year":"2021","journal-title":"Nature"},{"issue":"43","key":"10.1016\/j.canlet.2026.218841_bib121","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209021119","article-title":"Responsiveness to interleukin-15 therapy is shared between tissue-resident and circulating memory CD8(+) T cell subsets","volume":"119","author":"Jarjour","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.canlet.2026.218841_bib123","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148643","article-title":"T cell-derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death","volume":"6","author":"Chun","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218841_bib124","first-page":"1352","article-title":"IFN-gamma in the tumor microenvironment: dual roles in cancer progression and therapy","volume":"24","author":"Cui","year":"2025","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib125","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2590250","article-title":"Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity","volume":"17","author":"Pousse","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.canlet.2026.218841_bib126","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74276","article-title":"Molecular features underlying differential SHP1\/SHP2 binding of immune checkpoint receptors","volume":"10","author":"Xu","year":"2021","journal-title":"eLife"},{"issue":"30","key":"10.1016\/j.canlet.2026.218841_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.canlet.2026.218841_bib128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218841_bib129","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41590-022-01176-4","article-title":"LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation","volume":"23","author":"Guy","year":"2022","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.canlet.2026.218841_bib130","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.cell.2025.06.004","article-title":"Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity","volume":"188","author":"Du","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218841_bib131","article-title":"Role of CD155\/TIGIT in digestive cancers: promising cancer target for immunotherapy","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218841_bib132","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008972","article-title":"Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy","volume":"13","author":"Fischmann","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218841_bib133","article-title":"Diversity of immune checkpoints in cancer immunotherapy","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218841_bib134","first-page":"451","article-title":"Immune checkpoint inhibitors: breakthroughs in cancer treatment","volume":"21","author":"Kong","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"14","key":"10.1016\/j.canlet.2026.218841_bib135","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.7150\/thno.60040","article-title":"Converged Rab37\/IL-6 trafficking and STAT3\/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment","volume":"11","author":"Kuo","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib136","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12865-025-00751-2","article-title":"Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-\u03baB and STAT3 pathways highlighting mechanisms of immune evasion and potential for combination therapy","volume":"26","author":"Naito","year":"2025","journal-title":"BMC Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib137","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165544","article-title":"TGF-\u03b21 induces PD-1 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation","volume":"9","author":"Lei","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","article-title":"TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives","volume":"6","author":"Yan","year":"2025","journal-title":"Mol. Biomed."},{"issue":"7","key":"10.1016\/j.canlet.2026.218841_bib139","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","article-title":"Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade","volume":"5","author":"Roussel","year":"2021","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.canlet.2026.218841_bib140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/path.5877","article-title":"Presence of Tim3(+) and PD-1(+) CD8(+) T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features","volume":"257","author":"Klapholz","year":"2022","journal-title":"J. Pathol."},{"issue":"8038","key":"10.1016\/j.canlet.2026.218841_bib141","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-024-07943-7","article-title":"CTLA4 blockade abrogates KEAP1\/STK11-related resistance to PD-(L)1 inhibitors","volume":"635","author":"Skoulidis","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218841_bib142","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11033-025-11235-2","article-title":"CRISPR-Cas9 in leukemia immunotherapy: precision engineering of CAR-T cells and tumor-microenvironment modulation","volume":"53","author":"Gong","year":"2025","journal-title":"Mol. Biol. Rep."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:19:04Z","timestamp":1791339544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":142,"alternative-id":["S0304383526006051"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218841","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell exhaustion and senescence in cancer: Regulatory circuits and therapeutic state engineering","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218841"}}